Home Data Calendar Blog

XNCR

Tables

		2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Common Stock Value		0.62	0.62	0.61	0.61	0.61	0.60	0.60	0.60	0.60	0.60	0.59	0.58	0.58	0.58	0.58	0.57	0.57	0.57	0.57	0.57	0.56	0.56	0.56	0.56	0.47	0.47	0.47	0.47
Weighted Average Number Of Diluted Shares Outstanding		61.68	61.21	NA	60.62	59.81	59.77	NA	59.72	59.57	61.08	NA	NA	NA	NA	NA	57.27	57.06	56.95	NA	56.64	56.40	58.01	NA	58.31	NA	46.93	46.77	NA
Weighted Average Number Of Shares Outstanding Basic		61.68	61.21	NA	60.62	59.81	59.77	NA	59.72	59.57	59.41	NA	NA	NA	NA	NA	57.27	57.06	56.95	NA	56.64	56.40	56.30	NA	55.97	NA	46.93	46.77	NA
Earnings Per Share Basic		-1.07	-1.11	-0.31	-0.40	-0.37	-1.02	-0.21	-0.55	-0.57	0.40	1.26	-0.69	0.90	-0.04	-0.24	-0.22	-0.61	-0.14	-0.47	-0.18	-0.28	1.42	-0.32	0.06	-0.25	-0.33	-0.15	-0.31
Earnings Per Share Diluted		-1.07	-1.11	-0.31	-0.40	-0.37	-1.02	-0.21	-0.55	-0.57	0.39	1.21	-0.69	0.87	-0.04	-0.24	-0.22	-0.61	-0.14	-0.47	-0.18	-0.28	1.38	-0.32	0.05	-0.25	-0.33	-0.15	-0.31

		2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Revenue From Contract With Customer Excluding Assessed Tax		16.96	12.80	44.69	59.16	45.52	18.96	21.61	27.30	30.18	85.50	154.01	19.68	67.45	33.97	41.85	35.37	13.09	32.38	3.52	21.76	19.48	111.94	11.56	29.04	30.15	0.00	12.50	3.50
Revenues		16.96	12.80	44.69	59.16	45.52	18.96	21.61	27.30	30.18	85.50	154.01	19.68	67.45	33.97	41.85	35.37	13.09	32.38	3.52	21.76	19.48	111.94	11.56	29.04	30.15	0.00	12.50	3.50
Operating Expenses		79.28	70.66	79.70	77.43	71.52	78.33	64.20	65.65	58.17	59.03	62.36	60.98	58.36	49.64	55.55	52.09	50.69	41.16	34.09	36.04	39.06	33.70	32.65	28.39	24.82	23.58	21.01	19.86
Research And Development Expense		61.53	56.87	64.22	64.94	60.06	64.38	51.45	53.27	47.08	47.76	50.99	50.61	49.50	41.41	47.95	44.45	43.46	33.94	27.34	29.77	33.30	28.18	27.13	20.95	20.40	19.41	16.92	15.05
General And Administrative Expense		17.75	13.79	15.48	12.49	11.46	13.95	12.75	12.37	11.09	11.27	11.38	10.37	8.86	8.23	7.60	7.64	7.23	7.22	6.75	6.27	5.76	5.51	5.52	7.43	4.43	4.17	4.09	4.81
Operating Income Loss		-62.32	-57.85	-35.01	-18.27	-26.00	-59.37	-42.59	-38.35	-28.00	26.47	91.65	-41.30	9.09	-15.67	-13.70	-16.72	-37.60	-8.78	-30.57	-14.28	-19.57	78.24	-21.08	0.65	-13.88	-16.49	-7.67	-15.52
Interest Income Expense Net		NA	7.47	6.95	5.02	3.76	2.89	2.07	1.38	0.72	0.65	0.29	0.20	0.15	0.21	0.71	1.42	2.09	3.04	3.42	3.70	3.62	2.89	2.81	2.64	1.05	1.04	NA	NA
Interest Paid Net		0.01	0.01	0.00	0.01	0.01	0.01	0.00	0.00	0.01	0.00	0.00	0.00	0.01	0.00	0.00	0.00	0.01	0.01	0.00	0.00	0.00	0.00	0.01	0.00	0.01	0.00	0.00	0.00
Income Tax Expense Benefit		0.12	NA	NA	NA	NA	NA	-0.41	1.09	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	-0.29	-0.35	0.05	0.90	NA	NA	-1.09	0.17	0.28	0.17
Profit Loss		-67.41	-68.71	-19.26	-24.27	-21.95	-60.76	-12.04	-32.76	-33.97	23.59	73.06	-40.19	52.25	-2.49	-13.69	-12.55	-35.02	-8.07	-26.91	-10.22	-16.03	80.05	-18.20	3.15	-11.84	-15.56	-6.04	-15.47
Net Income Loss		-65.96	-68.03	-19.10	-24.27	-21.95	-60.76	-12.04	-32.76	-33.98	23.59	73.06	-40.19	52.25	-2.49	-13.69	-12.55	-35.02	-8.07	-26.91	-10.22	-16.03	80.05	-18.20	3.15	-11.84	-15.56	-6.88	-14.63
Comprehensive Income Net Of Tax		-66.46	-69.48	-17.10	-23.12	-20.19	-57.44	-9.12	-33.69	-35.80	17.98	71.63	-40.25	52.14	-2.46	-14.18	-13.47	-34.59	-8.18	-27.19	-10.42	-14.75	81.36	-16.83	2.82	-12.55	-15.42	-6.93	-14.39
Net Income Loss Available To Common Stockholders Basic		-65.96	-68.03	-19.10	-24.27	-21.95	-60.76	-12.04	-32.76	-33.98	23.59	73.06	-40.19	52.25	-2.49	-13.69	-12.55	-35.02	-8.07	-26.91	-10.22	-16.03	80.05	-18.20	3.15	-3.07	-22.65	-7.72	-15.47

		2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Assets		826.17	884.25	952.69	778.43	778.12	803.41	846.27	835.27	851.33	857.92	838.21	697.26	695.60	692.74	703.24	646.35	644.72	666.96	670.25	686.24	684.75	697.00	576.73	585.59	390.10	398.25	416.16	418.30
Liabilities		263.63	272.07	283.56	109.42	99.25	119.83	118.77	112.57	108.98	94.90	104.71	78.40	48.66	109.12	130.80	77.87	74.08	73.96	77.05	76.01	76.66	87.44	55.05	53.31	108.06	107.72	114.80	114.56
Liabilities And Stockholders Equity		826.17	884.25	952.69	778.43	778.12	803.41	846.27	835.27	851.33	857.92	838.21	697.26	695.60	692.74	703.24	646.35	644.72	666.96	670.25	686.24	684.75	697.00	576.73	585.59	390.10	398.25	416.16	418.30
Stockholders Equity		564.33	612.53	668.80	669.01	678.88	683.58	727.50	722.70	742.34	763.02	733.50	618.86	646.94	583.61	572.44	568.48	570.64	593.00	593.20	610.24	608.09	609.57	521.68	532.27	282.05	290.54	301.37	303.75

		2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Assets Current		554.47	562.25	623.16	571.18	593.56	629.98	675.34	668.00	585.94	505.97	424.37	329.63	480.97	591.17	637.67	570.88	603.39	588.11	558.40	573.76	527.01	488.67	315.73	286.92	230.88	217.81	210.98	166.09
Cash And Cash Equivalents At Carrying Value		30.77	31.03	53.79	52.73	34.71	72.39	53.94	52.65	49.41	78.27	143.48	41.20	115.84	176.97	163.54	58.09	109.53	73.81	50.31	51.19	32.56	21.86	26.25	35.00	16.53	13.63	11.22	13.56
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents		31.15	31.42	54.17	53.11	34.71	72.39	53.94	52.65	49.41	78.27	143.48	41.20	115.84	176.97	163.54	58.09	109.53	73.81	50.31	51.19	32.56	21.86	26.25	35.00	16.53	13.63	11.22	NA
Accounts Receivable Net Current		22.07	9.58	11.29	55.00	20.02	19.86	29.00	44.88	54.28	88.20	66.38	20.55	14.82	12.53	11.44	9.53	8.93	6.83	21.57	4.35	10.13	137.68	10.19	2.46	1.14	0.83	14.88	6.94
Prepaid Expense And Other Assets Current		23.99	16.74	18.14	21.64	22.17	22.09	23.28	22.89	19.73	23.01	23.88	20.88	15.59	14.16	10.73	10.19	7.40	6.48	6.55	7.53	11.31	9.43	10.38	12.10	5.61	7.03	7.62	4.37
Equity Securities Fv Ni		28.27	44.53	42.21	28.97	39.99	39.71	42.43	32.18	26.89	33.43	36.86	47.58	45.23	6.14	5.30	5.38	2.61	2.25	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Available For Sale Securities Debt Securities		554.23	615.33	643.24	433.25	NA	475.92	530.51	557.12	576.04	517.09	454.23	476.17	442.60	393.96	435.19	519.46	475.26	536.07	551.00	569.29	593.58	490.97	504.22	512.83	NA	359.37	367.51	379.09

		2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Property Plant And Equipment Gross		NA	NA	102.35	NA	NA	NA	87.47	NA	NA	NA	51.07	NA	NA	NA	38.71	NA	NA	NA	28.41	NA	NA	NA	21.24	NA	15.04	NA	NA	NA
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment		NA	NA	36.23	NA	NA	NA	28.29	NA	NA	NA	22.83	NA	NA	NA	17.03	NA	NA	NA	12.61	NA	NA	NA	9.43	NA	7.95	NA	NA	NA
Property Plant And Equipment Net		63.87	63.54	66.12	68.03	68.00	66.69	59.18	51.04	38.85	28.41	28.24	24.18	23.13	22.30	21.68	19.77	16.24	16.80	15.80	13.87	12.13	11.46	11.81	9.69	7.09	6.08	3.86	3.36
Intangible Assets Net Excluding Goodwill		18.78	18.85	18.66	18.74	18.71	18.24	18.50	18.09	17.94	16.71	16.49	16.68	16.38	15.55	15.98	15.32	15.16	14.64	14.42	14.03	13.52	12.74	11.97	11.68	11.15	11.04	10.87	10.89
Finite Lived Intangible Assets Net		NA	NA	8.54	NA	NA	NA	8.77	NA	NA	NA	7.27	NA	NA	NA	7.15	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Other Assets Noncurrent		0.50	0.50	0.65	0.66	0.60	0.60	0.61	0.61	0.61	0.61	0.65	33.45	4.35	10.42	0.21	8.61	8.79	9.19	0.31	10.19	10.73	11.27	0.31	0.31	0.27	0.27	0.21	0.10
Equity Securities Fv Ni		28.27	44.53	42.21	28.97	39.99	39.71	42.43	32.18	26.89	33.43	36.86	47.58	45.23	6.14	5.30	5.38	2.61	2.25	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Available For Sale Debt Securities Amortized Cost Basis		554.88	615.47	641.93	433.94	NA	479.54	537.46	566.98	584.97	524.20	455.73	476.23	442.60	393.85	435.10	518.88	473.77	535.01	549.83	567.84	591.94	490.62	505.18	515.16	NA	360.46	368.74	380.28

		2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Liabilities Current		80.08	79.40	84.71	53.04	44.63	65.06	63.84	90.03	75.04	60.94	70.74	44.32	45.96	99.93	121.06	70.49	66.45	65.92	66.56	64.31	63.71	73.32	53.85	52.03	101.34	100.33	107.43	106.88
Debt Current		6.95	7.95	6.33	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Accounts Payable Current		15.84	16.01	13.91	14.97	14.10	15.34	10.09	14.62	15.75	11.90	14.00	9.13	7.11	7.66	8.95	13.11	10.51	10.31	10.19	8.30	8.99	5.49	3.80	5.98	6.87	6.60	7.38	4.28
Accrued Liabilities Current		19.56	13.49	23.56	24.47	18.44	15.14	18.73	19.29	16.35	12.61	19.44	22.11	17.33	12.51	17.60	11.38	9.16	7.29	8.99	7.83	6.23	5.71	9.66	5.67	5.48	4.64	3.98	6.50

		2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Long Term Debt Noncurrent		12.31	12.49	14.64	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Minority Interest		-1.78	-0.34	0.34	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Operating Lease Liability Noncurrent		67.16	66.81	59.02	56.38	54.62	54.77	54.93	22.54	33.94	33.96	33.97	34.09	2.70	9.19	9.74	7.38	7.63	8.04	8.56	9.08	9.65	10.22	NA	NA	NA	NA	NA	NA

		2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Stockholders Equity		564.33	612.53	668.80	669.01	678.88	683.58	727.50	722.70	742.34	763.02	733.50	618.86	646.94	583.61	572.44	568.48	570.64	593.00	593.20	610.24	608.09	609.57	521.68	532.27	282.05	290.54	301.37	303.75
Stockholders Equity Including Portion Attributable To Noncontrolling Interest		562.54	612.19	669.13	NA	678.88	683.58	727.50	NA	NA	NA	733.50	NA	NA	NA	572.44	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Common Stock Value		0.62	0.62	0.61	0.61	0.61	0.60	0.60	0.60	0.60	0.60	0.59	0.58	0.58	0.58	0.58	0.57	0.57	0.57	0.57	0.57	0.56	0.56	0.56	0.56	0.47	0.47	0.47	0.47
Additional Paid In Capital		1162.73	1144.47	1131.27	1114.38	1101.13	1085.65	1072.13	1058.22	1044.17	1029.06	1017.52	974.51	962.34	951.15	937.52	919.39	908.08	895.86	887.87	877.72	865.16	851.89	845.37	839.13	570.67	566.61	562.02	557.47
Retained Earnings Accumulated Deficit		-598.37	-532.40	-464.37	-445.27	-421.00	-399.05	-338.29	-326.24	-293.49	-259.51	-283.10	-356.17	-315.97	-368.22	-365.74	-352.04	-339.49	-304.48	-296.40	-269.49	-259.27	-243.23	-323.28	-305.08	-287.29	-275.44	-259.88	-253.00
Accumulated Other Comprehensive Income Loss Net Of Tax		-0.65	-0.15	1.29	-0.71	-1.86	-3.62	-6.95	-9.88	-8.94	-7.12	-1.51	-0.07	-0.01	0.10	0.07	0.57	1.48	1.06	1.16	1.44	1.63	0.34	-0.97	-2.34	-1.81	-1.10	-1.24	-1.20
Minority Interest		-1.78	-0.34	0.34	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value		17.19	11.42	NA	12.90	13.56	12.60	NA	12.76	12.60	10.80	NA	8.94	9.35	8.29	NA	8.32	8.23	6.51	NA	9.51	9.30	5.86	5.08	6.12	3.44	3.60	3.45	3.16

		2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Net Cash Provided By Used In Operating Activities		-65.34	-55.26	181.21	-27.28	-38.20	-30.61	-24.43	-1.17	44.27	5.82	61.79	-39.02	-9.65	-29.97	17.08	-3.87	-27.68	9.46	-19.58	-6.48	109.16	-18.73	-16.78	-10.31	-6.67	-3.51	-12.96	-10.55
Net Cash Provided By Used In Investing Activities		66.02	32.32	-203.13	45.33	-1.41	48.14	24.55	3.12	-75.64	-71.76	7.86	-38.85	-53.31	38.05	78.78	-50.56	59.41	12.56	15.73	22.06	-102.43	13.67	6.87	5.86	8.94	4.93	9.53	8.55
Net Cash Provided By Used In Financing Activities		-0.94	0.19	22.98	0.36	1.92	0.92	1.17	1.29	2.51	0.73	32.63	3.23	1.84	5.34	9.59	2.99	4.00	1.47	2.97	3.05	3.97	0.67	1.17	4.15	0.62	0.99	1.10	1.03

		2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Net Cash Provided By Used In Operating Activities		-65.34	-55.26	181.21	-27.28	-38.20	-30.61	-24.43	-1.17	44.27	5.82	61.79	-39.02	-9.65	-29.97	17.08	-3.87	-27.68	9.46	-19.58	-6.48	109.16	-18.73	-16.78	-10.31	-6.67	-3.51	-12.96	-10.55
Net Income Loss		-65.96	-68.03	-19.10	-24.27	-21.95	-60.76	-12.04	-32.76	-33.98	23.59	73.06	-40.19	52.25	-2.49	-13.69	-12.55	-35.02	-8.07	-26.91	-10.22	-16.03	80.05	-18.20	3.15	-11.84	-15.56	-6.88	-14.63
Profit Loss		-67.41	-68.71	-19.26	-24.27	-21.95	-60.76	-12.04	-32.76	-33.97	23.59	73.06	-40.19	52.25	-2.49	-13.69	-12.55	-35.02	-8.07	-26.91	-10.22	-16.03	80.05	-18.20	3.15	-11.84	-15.56	-6.04	-15.47
Depreciation Depletion And Amortization		3.02	3.04	3.23	3.14	2.88	2.25	2.16	2.24	2.22	2.18	2.11	1.99	1.75	1.64	1.53	1.45	1.44	1.37	1.23	1.07	1.01	1.00	0.88	0.82	0.61	0.56	0.45	0.41
Increase Decrease In Accounts Payable		-0.17	2.10	-1.05	0.87	-1.25	5.25	-4.53	-1.13	3.84	-2.10	4.87	2.02	-0.55	-1.29	-4.16	2.60	0.20	0.12	1.88	-0.69	3.51	1.69	-2.19	1.07	0.27	-0.78	3.10	0.40
Share Based Compensation		17.19	11.42	14.70	12.90	13.56	12.60	12.74	12.76	12.60	10.80	10.39	8.94	9.35	8.29	8.56	8.32	8.23	6.51	7.18	9.51	9.30	5.86	5.08	6.12	3.44	3.60	3.45	3.16

		2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Net Cash Provided By Used In Investing Activities		66.02	32.32	-203.13	45.33	-1.41	48.14	24.55	3.12	-75.64	-71.76	7.86	-38.85	-53.31	38.05	78.78	-50.56	59.41	12.56	15.73	22.06	-102.43	13.67	6.87	5.86	8.94	4.93	9.53	8.55
Payments To Acquire Property Plant And Equipment		3.03	0.13	0.98	2.83	3.85	10.78	9.97	14.09	12.35	2.09	6.32	2.75	2.28	1.95	3.15	4.70	0.62	2.07	2.91	2.58	1.45	0.41	2.79	1.01	1.48	2.58	0.76	0.49

		2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Net Cash Provided By Used In Financing Activities		-0.94	0.19	22.98	0.36	1.92	0.92	1.17	1.29	2.51	0.73	32.63	3.23	1.84	5.34	9.59	2.99	4.00	1.47	2.97	3.05	3.97	0.67	1.17	4.15	0.62	0.99	1.10	1.03

		2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Revenues		16.96	12.80	44.69	59.16	45.52	18.96	21.61	27.30	30.18	85.50	154.01	19.68	67.45	33.97	41.85	35.37	13.09	32.38	3.52	21.76	19.48	111.94	11.56	29.04	30.15	0.00	12.50	3.50
Alexion Pharmaceuticals Inc		6.90	9.40	5.20	31.80	11.20	10.50	9.20	7.30	6.70	6.10	5.80	5.80	5.20	5.30	14.70	4.30	3.80	3.30	2.50	5.40	5.10	NA	11.00	9.00	NA	NA	NA	NA
Gilead		NA	NA	0.00	6.00	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.00	0.00	7.50	6.00	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Janssen		NA	NA	36.70	13.70	22.20	5.20	4.90	0.10	0.20	1.80	76.80	6.30	16.20	14.60	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Morpho Sys		1.60	2.90	2.10	2.70	2.00	1.80	2.20	2.10	1.20	2.30	2.00	1.30	1.20	13.90	1.30	25.20	0.00	12.50	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Shanghai Mabgeek Biotech Co. Ltd.		1.50	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Third Party License Agreement		7.00	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Zenas Bio Pharma Limited		NA	NA	0.00	0.00	10.00	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Shanghai Mabgeek Biotech Co. Ltd., Technology License Agreement		1.50	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Third Party License Agreement, Patent License Agreement		7.00	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Royalty		NA	NA	8.00	14.50	13.30	13.80	16.20	27.20	30.00	78.70	52.90	13.40	7.30	6.70	6.10	4.50	3.80	3.30	2.50	1.40	1.10	NA	NA	NA	NA	NA	NA	NA
License Agreement		8.50	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Milestone		0.00	0.50	27.50	46.00	10.00	5.00	0.50	0.00	0.00	5.00	7.00	0.00	1.50	12.50	12.40	25.00	0.30	12.50	-0.10	19.30	4.00	NA	11.50	9.00	NA	NA	NA	NA
Non Cash Royalty		8.50	12.30	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Revenue From Contract With Customer Excluding Assessed Tax		16.96	12.80	44.69	59.16	45.52	18.96	21.61	27.30	30.18	85.50	154.01	19.68	67.45	33.97	41.85	35.37	13.09	32.38	3.52	21.76	19.48	111.94	11.56	29.04	30.15	0.00	12.50	3.50
Alexion Pharmaceuticals Inc		6.90	9.40	5.20	31.80	11.20	10.50	9.20	7.30	6.70	6.10	5.80	5.80	5.20	5.30	14.70	4.30	3.80	3.30	2.50	5.40	5.10	NA	11.00	9.00	NA	NA	NA	NA
Gilead		NA	NA	0.00	6.00	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.00	0.00	7.50	6.00	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Janssen		NA	NA	36.70	13.70	22.20	5.20	4.90	0.10	0.20	1.80	76.80	6.30	16.20	14.60	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Morpho Sys		1.60	2.90	2.10	2.70	2.00	1.80	2.20	2.10	1.20	2.30	2.00	1.30	1.20	13.90	1.30	25.20	0.00	12.50	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Shanghai Mabgeek Biotech Co. Ltd.		1.50	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Third Party License Agreement		7.00	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Zenas Bio Pharma Limited		NA	NA	0.00	0.00	10.00	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Shanghai Mabgeek Biotech Co. Ltd., Technology License Agreement		1.50	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Third Party License Agreement, Patent License Agreement		7.00	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Royalty		NA	NA	8.00	14.50	13.30	13.80	16.20	27.20	30.00	78.70	52.90	13.40	7.30	6.70	6.10	4.50	3.80	3.30	2.50	1.40	1.10	NA	NA	NA	NA	NA	NA	NA
License Agreement		8.50	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Milestone		0.00	0.50	27.50	46.00	10.00	5.00	0.50	0.00	0.00	5.00	7.00	0.00	1.50	12.50	12.40	25.00	0.30	12.50	-0.10	19.30	4.00	NA	11.50	9.00	NA	NA	NA	NA
Non Cash Royalty		8.50	12.30	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA

Plots across concepts

Line plots across dimensions of each concept